期刊文献+

鲍曼不动杆菌院内获得性肺炎发生和死亡的危险因素分析 被引量:2

Risk factors for Acinetobacter baumannii hospital.acquired pneumonia and associated mortality
原文传递
导出
摘要 目的探讨鲍曼不动杆菌(鲍氏不动杆菌)院内获得性肺炎(Ab—HAP)的易感因素和死亡的危险因素。方法收集2012-2015年北京积水潭医院明确诊断的Ab—HAP患者65例,并随机收集同期非Ab—HAP患者80例作为对照组,分析人口学、基础疾病、治疗情况及转归等信息。采用Logistic回归法分析发生Ab—HAP的独立危险因素以及Ab—HAP患者30d死亡的独立危险因素。结果Ab—HAP组和对照组在合并基础病、意识障碍、APACHⅡ评分≥16、机械通气≥5d、碳青霉烯抗生素暴露史方面差异有统计学意义(χ2=36.327、31.208、72.616、22.029和64.476,P均〈0.01)。多因素分析显示,APACHⅡ评分≥16(OR=1.140,95%CI:1.058-1.229)、碳青霉烯抗生素暴露史(OR=7,118,95%CI:1.965-25.787)是发生Ab—HAP的独立危险因素。Logistic回归分析证实,降钙素原≥2ng/mL(OR=6.020,95%CI:7.428-2819.026)、肺炎严重性评分(PSI)≥Ⅲ级(OR=4.260,95%CI:3.185—1573.536)和脓毒性休克(OR=4.186,95%CI:2.056-2104.507)是Ab—HAP患者30d死亡的独立危险因素。结论APACHⅡ评分≥16、碳青霉烯抗生素暴露史能增加Ab—HAP发生率;PSI≥Ⅲ级、降钙素原≥2ng/mL和脓毒休克是Ab—HAP患者30d死亡的独立危险因素。 Objective To study the risk factors for Acinetobacter Baumannii hospital-acquired pneumonia (Ab-HAP). Methods Data of 65 patients diagnosed with Ab-HAP during 2012 to 2015 was collected, and 80 random cases of non-Acinetobacer Baumannii gram-negative bacterial hospital-acquired pneumonia were as control group. Information such as demographic characteristics, underlying diseases, treatment and outcomes was analyzed. Logistic regression was performed to identify the independent risk factors of Ab-HAP and risk factors for 30-day mortality. Results The differences of prevalence of underlying diseases, confusion, APACHⅡ score ≥16, mechanical vetilation ≥ 5 days and history of imipenem exposure between Ab-HAP group and control group had statistical significance (χ2=36.327, 31.208, 72.616, 22.029 and 64.476,P all〈0.01). Multiple-factor analysis showed that APACHⅡ seore≥ 16 (0R=1.140,95%CI:1.058-1.229) and history of imipenem exposure (OR=7.118, 95%CI:1.965-25.787) were independent risk factors for Ab-HAP. Logistic regression confirmed procalcitonin ≥2 ng/mL (OR =6.020,95% CI:7.428-2 819.026), pneumonia severvity index (PSI)≥Ⅲ risk class ( OR =4.260,95 % CI:3.185-1573.536) and septic shock (OR =4.186,95% CI:2.056-2 104.507)were associated with 30-day mortality. Conclusions APACH Ⅱ score ≥ 16 and history of imipenem exposure can increase the occurrence rate of Ab-HAP.Procalcitonin ≥2 ng/mL, PSI≥Ⅲrisk class and septic shock are risk factors for 30-day mortality of Ab- HAP.
出处 《国际流行病学传染病学杂志》 CAS 2017年第4期250-254,共5页 International Journal of Epidemiology and Infectious Disease
关键词 鲍氏不动杆菌 院内获得性肺炎 易感因素 病死率 Acinetobacter baumannii Hospital-acquired pneumonia Risk factors Mortality
  • 相关文献

参考文献4

二级参考文献39

  • 1周颖杰,李光辉.成人及儿童复杂性腹腔内感染的诊断与处理:美国外科感染学会及美国感染病学会指南[J].中国感染与化疗杂志,2010,10(4):241-247. 被引量:241
  • 2社区获得性肺炎诊断和治疗指南[J].中华结核和呼吸杂志,2006,29(10):651-655. 被引量:3062
  • 3Cristina ML, Spagnolo AM, Ottria G, et al. Spread of multidrugcaib叩enem-resistant Acinetobacter baumarwii in different wards of anItalian hospital. Am J Infect Control, 2011,39(9) : 790-794.
  • 4McGrath EJ, Chora T, Abdel-Haq N, et al. An outbreak ofcaifc^jenem-resistant Acinetobacter baumannii infection in a neonatalintensive care unit: investigation and control. Infect Control HospEpidemiol, 2011,32(1):34-41.
  • 5Chen Z, Liu W, Zhang Y, et al. Molecular epidemiology ofcaibapenem-resistant Acinetobacter spp. from XiangYa Hospital, inHunan Province, China. J Basic Microbiol, 2012,In press.
  • 6Liakopoulos A, Miriagou V, Katsifas EA, et al. Identification ofOXA-23-producing Acinetobacter baumannii in Greece, 2010 to 2011.Euro SurveiU, 2012, 17(11).pii: 20117.
  • 7Lin WR, Lu PL, Siu LX, et al. R^)id control of a hospital-wideoutbreak caused by extensively drug-resistant OXA-72-producingAcinetobacter baumannii. Kaohsiung J Med Sci, 2011, 27(6): 207-214..
  • 8Montealegre MC, Maya JJ, Correa A, et al. First Identification ofOXA-72 CaAqjenemase from Acinetobacter pittii in Colombia.Antimicrob Agents Chemother, 2012,56 ( 7 ) : 3996-3998.
  • 9Al-Sweih NA, AI-Hubail M, Eotimi VO. TTiree distinct clones ofcaii)?^)enem-resistant Acinetobacter baumannii with high diversity ofcaibapenemases isolated frcan patients in two hospitals in Kuwait. JInfect Public Health, 2012 , 5(1) : 102-108.
  • 10Lee K, Yun H, Yong D, et al. Novel acquired metallo-beta-blactamase gene, bla(SIM-l),in a class 1 integron from Acinetobaterbaumannii clinical isolates from Korea. AntimicrcA) Agents Chemother,2005 , 49(11): 4485^491.

共引文献1758

同被引文献23

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部